Dyne Therapeutics Inc.

NASDAQ: DYN · Real-Time Price · USD
12.13
-0.20 (-1.62%)
At close: Aug 19, 2025, 11:43 AM

Dyne Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-110.86M -115.36M -89.54M -97.13M -65.1M -65.65M -66.64M -60.21M -64.9M -44.19M -38.83M -41.38M -52.3M -35.58M -51.79M -42.58M -29.95M -24.97M
Depreciation & Amortization
503K 502K 1.02M 438K 400K 386K 567K 431K 431K 412K 401K 397K 460K 425K 341K 260K 249K 238K
Stock-Based Compensation
10.52M 13.02M 10.48M 8.74M 6.74M 19.91M 5.73M 4.88M 4.75M 4.62M 3.83M 3.83M 3.03M 4.49M 6.01M 3.64M 4.24M 3.65M
Other Working Capital
-5M 5M -4.09M 765K -3.14M -4.07K 4.12M -4.96M 5.57M -1.39M 510K -4M 14.82M -15.48M 11.31M 6.21M -22.3M 331K
Other Non-Cash Items
1.53M -452K -635K -866K -1.15M 173K -921K 166K 243K 171K 246K -489K 1.14M 1.68M -718K -13K -8K -7K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 727K -365K -362K n/a n/a n/a n/a n/a 745K 697K 654K 492K
Change in Working Capital
3.6M -3.6M -5.08M 14.18M 4.24M -32.83M 25.53M 4.5M 4.2M -7.92M 5.16M -5.16M 16.36M -21.75M 17.34M 11.05M -21.33M 2.2M
Operating Cash Flow
-94.7M -105.89M -84.33M -74.63M -54.87M -78.54M -35.01M -50.6M -55.64M -46.91M -29.19M -42.8M -30.91M -50.74M -28.07M -26.95M -46.15M -18.39M
Capital Expenditures
-60K -981K -1.07M -253K -857K -191K -82K -167K -250K -230K -519K -886K -261K -1.4M -1.99M -881K -738K -9K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 7.47K -12.99K -17.48K 23K 34K -52.54K n/a 30K 8K n/a n/a n/a
Purchase of Investments
-40.93M -65.97M -52.71M -57.04M -26.3M -181.39M 23K -9.58M -18M -16.69M -26.46M -5.18M -34.2M -55.33M -28.51M -51.65M -24.38M -132.19M
Sales Maturities Of Investments
47.75M 68.41M 37.78M 37.89M 38.34M 1.74M 26.28M 22.57M 35.48M 43.98M 46.22M 57.73M 52.91M 54.59M 30.27M 49.68M 18.68M 3.82M
Other Investing Acitivies
14K n/a n/a n/a n/a -179.65K -30.47K 12.99K 17.48K -23K -34K 52.54K 18.7M -30K -8K -1.97K -5.7K -128.37K
Investing Cash Flow
6.77M 1.46M -16.01M -19.4M 11.17M -179.84M 26.2M 12.82M 17.23M 27.06M 19.24M 51.66M 18.44M -2.14M -235K -2.85M -6.43M -128.38M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
100.77M 588K 3.64M 18.01M 4.28M 10.92M 148K 454K 764K 587K 342K 70K 99K 18K 89K 457K 25K 13K
Financial Cash Flow
100.77M 141.24M 3.64M 18.01M 379.86M 408.39M 147K 454K 24.91M 28.82M 37.2M 70K 99K 18K 89K 457K 25K 157.25M
Net Cash Flow
12.85M 36.81M -96.71M -76.02M 336.16M 150.01M -8.65M -37.33M -13.5M 8.97M 27.25M 8.92M -12.37M -52.86M -28.21M -29.34M -52.56M 10.48M
Free Cash Flow
-94.76M -106.87M -85.41M -74.88M -55.73M -78.73M -35.09M -50.77M -55.89M -47.14M -29.71M -43.69M -31.17M -52.14M -30.06M -27.83M -46.89M -18.4M